| 规格: | 98% |
| 分子量: | 479.45 |
| 包装 | 价格(元) |
| 250mg | 电议 |
| 500mg | 电议 |
Background:
CSF1R-IN-1 is a CSF1R inhibitor with an with an IC50 of 0.5 nM.
CSF1R is thought to play an important role in recruitment and differentiation of tumor-associated macrophages (TAMs). CSF1R-IN-1 (compound 22) shows good intestinal permeability in a Caco2 assay[1].
CSF1R-IN-1 has favorable pharmacokinetics when dosed orally to mice. It appears suitable for in vivo pharmacology testing in the appropriate preclinical tumor model to demonstrate proof of concept.[1].|| Animal Model:|Male CD-1 mice, 25-35 grams (8-11 weeks old)[1]|Dosage:|2 mg/kg IV or 10 mg/kg orally (Per Os)|Administration:|i.v. or oral|Result:|
[1]. Ramachandran SA, et al. Design, synthesis and optimization of bis-amide derivatives as CSF1R inhibitors. Bioorg Med Chem Lett. 2017 May 15;27(10):2153-2160.
m.cnreagent.com